Terms: = Breast cancer AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL AND Treatment
4 results:
1. Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types.
Andrianto A; Sudiana IK; Suprabawati DGA; Notobroto HB
F1000Res; 2023; 12():841. PubMed ID: 38046195
[No Abstract] [Full Text] [Related]
2. MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung cancers Driven by
Sato H; Schoenfeld AJ; Siau E; Lu YC; Tai H; Suzawa K; Kubota D; Lui AJW; Qeriqi B; Mattar M; Offin M; Sakaguchi M; Toyooka S; Drilon A; Rosen NX; Kris MG; Solit D; De Stanchina E; Davare MA; Riely GJ; Ladanyi M; Somwar R
Clin Cancer Res; 2020 Jun; 26(12):2932-2945. PubMed ID: 32122926
[TBL] [Abstract] [Full Text] [Related]
3. [Establish and analyze the predictive model of early stage brain metastases in patients with breast cancer].
Wang Q; Wu S; Sun B; Huang Z; Meng X; Huang Y
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3927-9. PubMed ID: 27122216
[TBL] [Abstract] [Full Text] [Related]
4. High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting.
Fuchs EM; Köstler WJ; Horvat R; Hudelist G; Kubista E; Attems J; Zielinski CC; Singer CF
Int J Cancer; 2014 Jul; 135(1):224-31. PubMed ID: 24311197
[TBL] [Abstract] [Full Text] [Related]
